United States

People: Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

22 Sep 2017
Change (% chg)

$-0.15 (-0.64%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Smith, Ian 

Mr. Ian F. Smith, CPA, is an Independent Director of Acorda Therapeutics, Inc., since February 2007. Mr. Smith currently serves as Executive Vice President and Chief Operating and Financial Officer of Vertex Pharmaceuticals Incorporated, a position he has held since January 2017. Prior to that, from February 2006 to January 2017 he served as Executive Vice President and Chief Financial Officer. From November 2003 to February 2006, he was Senior Vice President and Chief Financial Officer, and from October 2001 to November 2003, he served as Vice President and Chief Financial Officer, at Vertex. From 1999 to 2001, Mr. Smith served as a partner in the Life Science and Technology Practice Group of Ernst & Young LLP. Mr. Smith initially joined Ernst & Young’s U.K. firm in 1987, and then joined its Boston office in 1995. Mr. Smith currently is a member of the board of directors of Infinity Pharmaceuticals, Inc. and Ophthotech Corporation. Mr. Smith holds a B.A. in accounting and finance from Manchester Metropolitan University, U.K., is a member of the American Institute of Certified Public Accountants and is a Chartered Accountant of England and Wales. Mr. Smith has extensive global financial and accounting experience and possesses an understanding of financial matters and the preparation and analysis of financial statements.

Basic Compensation

Total Annual Compensation, USD 76,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 178,766
Fiscal Year Total, USD 254,766

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Ron Cohen


Richard Batycky


David Lawrence


Andrew Blight


Jane Wasman


Burkhard Blank

As Of  30 Dec 2016